Demerecviridae Bacteriophage Against Klebesiella Pneumoniae (113.073 Bp), Drexlerviridae Bacteriophage Against Klebesiella Pneumoniae (45.423 Bp), Myoviridae Bacteriophage Against Klebesiella Pneumoniae (169.802 Bp), Myoviridae Bacteriophage Against Pseudomonas Aeruginosa (65.855 Bp), Myoviridae Bacteriophage Against Pseudomonas Aeruginosa (92.792 Bp), Siphoviridae Bacteriophage Against Pseudomonas Aeruginosa (43.020 Bp) — Drug Intelligence | 2 EU Trials

Filter these 2 trials by condition, phase, country and more.

2 Registered trials

0 Recruiting

0 Completed trials

1 Sponsors

3 Countries

Phase I (FiH)

Phase I (FiH): 2

Oversight events:

1 corrective measure across 1 trial

Sponsors using this IMP

2 total

Clinical trial to assess the safety and tolerability of TP-122A for the treatment of ventilator-associated pneumonia. Not authorised

2023-508825-29-00 Phase I (FiH) 1 country Technophage Investigacao E Desenvolvimento Em Biotecnologia S.A.
Clinical trial to assess the safety and tolerability of TP-122A for the treatment of ventilator-associated pneumonia. Pending

2025-521533-85-00 Phase I (FiH) 2 countries Technophage Investigacao E Desenvolvimento Em Biotecnologia S.A.

Showing 1–2 of 2 trials